Compare Comfort Systems USA Inc (FIX) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Comfort Systems USA Inc vs Medpace Holdings Inc — how do they compare? Comfort Systems USA Inc trades at $1,656.78 (market cap $61.14B), while Medpace Holdings Inc trades at $533.89 (market cap $15.11B). The key difference: Comfort Systems USA Inc is far larger — about 4× Medpace Holdings Inc's market cap, and Comfort Systems USA Inc pays a 0.15% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| FIX | MEDP | |
|---|---|---|
Market Cap | $61.14B | $15.11B |
Sector | Technology | Technology |
52-Week High | $2.07K | $620.59 |
52-Week Low | $532.14 | $308.88 |
Enterprise Value | $60.42B | $14.58B |
Dividend Yield | 0.15% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Comfort Systems USA (FIX) trades at $1,694.14, down 4.56% amid bearish technical signals, though fundamentals remain strong with Q1 2026 EPS beating estimates at $10.51 versus $6.81 expected. Revenue growth is robust, projected to rise from $9.10B in 2025 to $10.1B in 2026, while net profit margins improve to 12.07%. The company benefits from AI infrastructure demand and a record backlog, though valuation multiples appear elevated with a P/E of 50.14.
Outlook is mixed: analyst consensus is bullish with a $2,100 price target and 55.56% buy ratings, but technical indicators signal near-term pressure. Key risks include execution challenges from rapid growth and premium valuation. The stock offers growth exposure to data center and construction markets, but investors should weigh high multiples against earnings momentum.
Medpace (MEDP) trades at $534.85, down 0.25% on the day, with a bullish technical signal from moving averages and RSI near oversold levels. The company shows strong profitability with a 17.19% net income margin and 77.25% ROE, though valuations are elevated with a P/E of 33.31. Recent earnings have consistently beaten estimates, and cash flow is projected to improve in 2026. News highlights focus on CRO demand shifts and a class action lawsuit from June 2026.
Outlook remains mixed; strong earnings momentum and operational efficiency support upside, but high valuation and legal overhangs pose risks. Analyst consensus is cautious with a $497 price target below current levels, suggesting limited near-term appreciation potential amid balanced investor sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Comfort Systems USA Inc
Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
